Vai al contenuto principale della pagina
Titolo: |
Nanoparticles for drug delivery / / K.S. Joshy, Sabu Thomas, Vijay Kumar Thakur, editors
![]() |
Pubblicazione: | Singapore : , : Springer, , [2021] |
©2021 | |
Descrizione fisica: | 1 online resource (214 pages) |
Disciplina: | 615.6 |
Soggetto topico: | Drug delivery systems |
Nanoparticles | |
Nanomedicine | |
Persona (resp. second.): | Joshy K. S |
ThomasSabu | |
ThakurVijay Kumar <1981-> | |
Nota di contenuto: | Intro -- Preface -- Contents -- Editors and Contributors -- 1 Nanomaterials for Cancer Therapeutics -- Abstract -- 1 Introduction -- 2 Molybdenum-Based Nanoparticles -- 3 Iron and Other Magnetic Nanomaterials -- 4 Chitosan-Based Nanoparticles -- 5 Polymer-/Polyamino Acids-Based Nanoparticles -- 6 Plant Viral Nanoparticles -- 7 Gold Nanoparticles -- 8 Quantum Dots -- 9 Recent Examples of Other Nanoparticles-Based Cancer Therapeutics -- 10 Nanoparticles-Based Cancer Therapeutics in the Market -- 11 Nanodiagnostics for Cancer Treatment -- 12 Conclusion -- References -- 2 Biomaterials and Its Advances for Delivering Anticancer Drugs -- Abstract -- 1 Introduction -- 2 Classes of Biomaterials for Anticancer Activity -- 3 Natural Biomaterials -- 3.1 Collagen -- 3.2 Alginates -- 3.3 Hyaluronic Acid (HA) -- 3.4 Chitosan -- 3.5 Cellulose -- 3.6 Cyclodextrins (CD) -- 3.7 Silk -- 4 Inorganic Biomaterials -- 4.1 Titanium and Selenium -- 4.2 Calcium Phosphate -- 4.3 Silica -- 5 Synthetic Biomaterials -- 5.1 Carbon Nanotubes (CNTs) -- 5.2 Graphene -- 5.3 Poly(Lactic Acid) (PLA) -- 5.4 Poly(Ethylene Glycol) (PEG) -- 5.5 Poly(ɛ-Caprolactone) (PCL) -- 5.6 Polyanhydrides -- 5.7 Polyurethanes (PU) -- 5.8 Conducting Polymers -- 6 Hybrid Materials -- 7 Triggerable Biomaterials -- 7.1 Magnetic Responsive Biomaterials -- 7.2 pH-Responsive Biomaterials -- 7.3 Temperature-Responsive Biomaterials -- 7.4 Redox Responsive Biomaterials -- 7.5 Enzymes and Hydrolysis Sensitive Polymers -- 7.6 Light Responsive Biomaterials -- 7.7 Electrically Responsive Biomaterials -- 7.8 Sound Responsive Biomaterials -- 7.9 Swelling and Shrinking Biomaterials -- 8 Commercially Available Products -- 9 Conclusions -- References -- 3 Stimuli-responsive Hybrid Polymeric Nanoparticles for Targeted Drug Delivery -- Abstract -- 1 Introduction -- 2 Exogenous Stimuli-Responsive Polymeric Nanoparticles. |
2.1 Light Responsive PNPs -- 2.2 Magnetic Responsive PNPs -- 2.3 Thermoresponsive PNPs -- 2.4 Electroresponsive PNPs -- 3 Endogenous Stimuli-Responsive Polymeric Nanoparticles -- 3.1 Redox-Responsive PNPs -- 3.2 pH-Responsive PNPs -- 3.3 Enzyme Responsive PNPs -- 4 Dual and multistimuli-responsive PNPs -- References -- 4 Hybrid Nanoparticles in Image-Guided Drug Delivery -- Abstract -- 1 Introduction -- 2 Principle -- 3 Hybrid Nanoparticles (HNPs) -- 4 Synthesis, Characterization and Biological Responses of Hybrid Nanoparticles (HNPs) -- 5 General Principles -- 6 Physical Methods -- 7 Photochemical Approach -- 8 Ionizing Radiation -- 9 Microwave Radiation -- 10 Chemical Synthesis Methods -- 11 Hydrothermal/Solvothermal Approach -- 12 Wet-Chemical Approach -- 13 Seed-Growth Approach -- 14 Sol-Gel Approach -- 15 Sonochemical Approach -- 16 Co-precipitation Approach -- 17 Toxicity, Bioavailability and Mode of Action of HNPs -- 18 Applications of HNPs -- References -- 5 Ceramic-Based Hybrid Nanoparticles in Drug Delivery -- Abstract -- 1 Introduction -- 2 Calcium Phosphate-Based Hybrid Ceramic Nanoparticles -- 3 Calcium Carbonate Nanoparticles -- 4 Silica-Based Hybrid Nanoparticles -- 5 Titania-Based Ceramic Nanoparticles -- 6 Zirconia Oxide-Based Hybrid Nanoparticles -- 7 Boron Carbide-Based Nanoparticles -- 8 Conclusion -- References -- 6 Biomaterials for Anticancer Drugs -- Abstract -- 1 Introduction -- 1.1 Cancer -- 2 Oral Chemotherapy -- 3 Biomaterial for Anticancer Drugs -- 3.1 Prodrugs -- 3.2 Nanoemulsions -- 3.3 Dendrimers -- 3.4 Micelles -- 3.5 Liposomes -- 3.6 Solid Lipid Nanoparticles -- 3.7 Nanoparticles of Biodegradable Polymers -- 4 Natural Products as Anticancer Drugs -- 4.1 Curcumin-Based Materials for Drug Delivery -- 5 Conclusion -- References -- 7 Quantum Dots in Drug Delivery -- Abstract -- 1 Introduction. | |
2 An Overview About the Structure and Synthesis of QDs -- 3 QDs Bioengineering Strategies -- 4 Engineered QDs in Cancer Targeted Drug Delivery Applications -- Acknowledgements -- References -- 8 Nanotechnology and Its Implication in Antiviral Drug Delivery -- Abstract -- 1 Introduction -- 1.1 The Virus -- 1.2 Life Cycle of HIV -- 1.2.1 Binding and Fusion -- 1.2.2 Reverse Transcription -- 1.2.3 Integration -- 1.2.4 Replication -- 1.2.5 Assembly -- 1.2.6 Budding -- 1.3 HIV Transmission -- 1.4 HIV Pathogenesis -- 1.4.1 HIV/Host Cell Interaction -- 1.5 The Complexity of HIV/AIDS -- 1.6 Detection of HIV -- 1.7 HIV/AIDS Current Therapeutic Strategies -- 1.7.1 Administration Routes -- 1.7.2 Major Setbacks for Anti-Retroviral Therapy for HIV/AIDS -- 1.8 Nanotechnology in Medicine -- 1.8.1 Nanotechnology Approaches in HIV/AIDS Management -- 1.9 Nanocarrier-Based Drug Delivery Systems -- 1.9.1 Dendrimers -- 1.9.2 Polymeric Nanoparticles -- 1.9.3 Inorganic Nanoparticle -- 1.9.4 Metal Based Nanoparticle -- 1.9.5 Liposomes -- Solid Lipid Nanoparticles -- Nanostructured Lipid Carriers (NLC) -- Lipid Drug Conjugates (LDC) -- Lipid-Polymer Hybrid Nanoparticles -- 1.10 Methods of Preparation of Lipid-Based Drug Delivery Systems -- 1.10.1 Homogenization -- 1.10.2 Hot Homogenization -- 1.10.3 Cold Homogenization -- 1.10.4 Ultrasonication or High-Speed Homogenization -- 1.10.5 Solvent Emulsification/Evaporation -- 1.10.6 Microemulsion -- 1.10.7 Supercritical Fluid Technique -- 1.10.8 Spray Drying Method -- 1.10.9 Double Emulsion Method -- 1.11 Synthesis of Polymeric Nanoparticles -- 1.11.1 Nanoprecipitation -- 1.11.2 Salting Out -- 1.11.3 Emulsification Diffusion -- 1.11.4 Emulsification Evaporation -- 1.11.5 Double Emulsion -- 1.12 Synthesis and Fabrication of Lipid-Polymer Hybrid Nanoparticles -- 1.12.1 Two-Step Method -- 1.12.2 One-Step Method -- 2 Conclusions. | |
References. | |
Titolo autorizzato: | Nanoparticles for drug delivery ![]() |
ISBN: | 981-16-2119-5 |
Formato: | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione: | Inglese |
Record Nr.: | 9910485607103321 |
Lo trovi qui: | Univ. Federico II |
Opac: | Controlla la disponibilità qui |